Skip to main content
Clinical Trials/NCT06567873
NCT06567873
Completed
Not Applicable

Assessment of Preoperative Gastric Content With Ultrasound in Patients Reporting Cannabis Use

Hospital for Special Surgery, New York1 site in 1 country40 target enrollmentMay 9, 2025

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cannabis Use
Sponsor
Hospital for Special Surgery, New York
Enrollment
40
Locations
1
Primary Endpoint
Incidence of delayed gastric emptying
Status
Completed
Last Updated
4 months ago

Overview

Brief Summary

The aim of this study is to perform bedside gastric point of care ultrasound (POCUS) exams to assess the gastric volume and content (clear liquids vs solid food) perioperatively in patients who report cannabis use.

Detailed Description

Cannabis use in the United States has continued to increase in recent years, particularly in the adult population. Ease of access through legalization paired with improved public perception has contributed to the uptick in cannabis use. The subset of cannabis users suffering from pain who present for surgery pose a risk for perioperative aspiration due to the slowing of gastric motility due to cannabis use. There is currently no adapted NPO guideline to account for cannabis use. Gastric Ultrasound (GUS) can be used as a bedside tool for assessing a patient's stomach contents and risk of aspiration. GUS can identify whether a patient's stomach is empty or filled with clear liquid, thick liquid, or solid food. The volume of the stomach can be accurately calculated if there is clear liquid content. A full stomach is categorized as those with solid or thick liquid content or with clear liquid measuring more than 1.5 ml/kg body weight. As GUS is noninvasive and does not pose risk to patients, it is a useful tool assessing aspiration risk in the preoperative period.

Registry
clinicaltrials.gov
Start Date
May 9, 2025
End Date
October 14, 2025
Last Updated
4 months ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Hospital for Special Surgery, New York
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Any patient reporting preoperative cannabis usage within 1 month of surgery date

Exclusion Criteria

  • Patient refusal to participate
  • Patient with gastric bypass or any other gastric surgery
  • Large hiatal hernia
  • Patients with large ascites
  • Patients on peritoneal dialysis
  • Emergency surgery
  • Pre-existing diagnosis of gastroparesis
  • Parkinson's disease
  • Currently taking metformin
  • Chronic kidney disease stage 3 or higher

Outcomes

Primary Outcomes

Incidence of delayed gastric emptying

Time Frame: This will be measured pre-operatively in the holding room area.

A full stomach on gastric ultrasound is defined by the presence of either solid food, thick liquids, or a specific volume (\>1.5 ml/kg) of clear liquids on gastric ultrasound.

Secondary Outcomes

  • Nothing by mouth (NPO) intervals(This will be measured pre-operatively in the holding room area.)
  • Time interval since last cannabis use(This will be measured pre-operatively in the holding room area.)
  • Presence of gastric peristalsis(This will be measured pre-operatively in the holding room area.)

Study Sites (1)

Loading locations...

Similar Trials